FI953899A0 - Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi - Google Patents
Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksiInfo
- Publication number
- FI953899A0 FI953899A0 FI953899A FI953899A FI953899A0 FI 953899 A0 FI953899 A0 FI 953899A0 FI 953899 A FI953899 A FI 953899A FI 953899 A FI953899 A FI 953899A FI 953899 A0 FI953899 A0 FI 953899A0
- Authority
- FI
- Finland
- Prior art keywords
- helicobacter
- treatment
- diseases caused
- substituted
- derivatives
- Prior art date
Links
- 241000589989 Helicobacter Species 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- VIXWGKYSYIBATJ-UHFFFAOYSA-N pyrrol-2-one Chemical class O=C1C=CC=N1 VIXWGKYSYIBATJ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93200474 | 1993-02-19 | ||
| PCT/EP1994/000380 WO1994018978A1 (en) | 1993-02-19 | 1994-02-09 | Substituted azolone derivatives for treating diseases caused by helicobacter |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI953899A0 true FI953899A0 (fi) | 1995-08-18 |
| FI953899A FI953899A (fi) | 1995-08-18 |
Family
ID=8213653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI953899A FI953899A (fi) | 1993-02-19 | 1995-08-18 | Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5650411A (pl) |
| EP (1) | EP0684821A1 (pl) |
| JP (1) | JPH08506821A (pl) |
| CN (1) | CN1118138A (pl) |
| AP (1) | AP435A (pl) |
| AU (1) | AU675508B2 (pl) |
| CA (1) | CA2155830A1 (pl) |
| FI (1) | FI953899A (pl) |
| HU (1) | HUT73662A (pl) |
| IL (1) | IL108703A (pl) |
| LT (1) | LT3214B (pl) |
| MX (1) | MX9401294A (pl) |
| NO (1) | NO953254L (pl) |
| NZ (1) | NZ261854A (pl) |
| PL (1) | PL174836B1 (pl) |
| RU (1) | RU2128659C1 (pl) |
| TW (1) | TW279864B (pl) |
| WO (1) | WO1994018978A1 (pl) |
| ZA (1) | ZA941137B (pl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5703236A (en) * | 1993-12-21 | 1997-12-30 | Schering Corporation | Tetrahydrofuran antifungals |
| DE69523581T2 (de) * | 1994-04-06 | 2002-07-11 | Janssen Pharmaceutica N.V., Beerse | Anti-helicobacter ester- oder carbamatderivate von azolonen |
| US5639754A (en) * | 1994-07-12 | 1997-06-17 | Janssen Pharmaceutica N.V. | Urea and thiourea derivatives of azolones |
| US5637592A (en) * | 1994-07-12 | 1997-06-10 | Janssen Pharmaceutica N.V. | Acyl derivatives of azolones |
| US5607932A (en) * | 1994-07-12 | 1997-03-04 | Janssen Pharmaceutica N.V. | Heterocyclic derivatives of azolones |
| CA2160423A1 (en) * | 1994-11-02 | 1996-05-03 | Hemant N. Joshi | Salts of nefazodone having improved dissolution rates |
| GB9524754D0 (en) * | 1995-12-04 | 1996-04-24 | Symmetricom Inc | Mobile position determination |
| RU2205179C2 (ru) | 1997-10-27 | 2003-05-27 | НьюроСёрч А/С | Производное гомопиперазина и фармацевтическая композиция |
| US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
| US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
| US6369087B1 (en) * | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
| US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
| US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
| WO2004083235A2 (en) * | 2003-03-19 | 2004-09-30 | Exelixis Inc. | Tie-2 modulators and methods of use |
| CA2673853C (en) * | 2006-12-26 | 2017-10-31 | Lantheus Medical Imaging, Inc. | Ligands for imaging cardiac innervation |
| CN102234267A (zh) * | 2010-04-21 | 2011-11-09 | 中国科学院上海药物研究所 | 新型三氮唑类抗真菌化合物、其药物组合物及其制备方法和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4724239A (en) * | 1985-09-16 | 1988-02-09 | Morgan Lee R | Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine |
| CA1292472C (en) * | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
| US4791111A (en) * | 1985-12-23 | 1988-12-13 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties |
| CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
| CA2076257A1 (en) * | 1991-09-13 | 1993-03-14 | Jan Heeres | 4-¬4-¬4-(4-hydroxyphenyl)-1- piperazinyl|phenyl|-5-methyl-3h -1,2,4-triazol-3-one derivatives |
-
1994
- 1994-02-02 TW TW083100854A patent/TW279864B/zh active
- 1994-02-09 US US08/491,960 patent/US5650411A/en not_active Expired - Fee Related
- 1994-02-09 EP EP94907534A patent/EP0684821A1/en not_active Withdrawn
- 1994-02-09 WO PCT/EP1994/000380 patent/WO1994018978A1/en not_active Application Discontinuation
- 1994-02-09 JP JP6518613A patent/JPH08506821A/ja active Pending
- 1994-02-09 HU HU9501923A patent/HUT73662A/hu unknown
- 1994-02-09 PL PL94310348A patent/PL174836B1/pl unknown
- 1994-02-09 NZ NZ261854A patent/NZ261854A/en unknown
- 1994-02-09 AU AU61081/94A patent/AU675508B2/en not_active Ceased
- 1994-02-09 RU RU95122796A patent/RU2128659C1/ru active
- 1994-02-09 CA CA002155830A patent/CA2155830A1/en not_active Abandoned
- 1994-02-09 CN CN94191221A patent/CN1118138A/zh active Pending
- 1994-02-18 MX MX9401294A patent/MX9401294A/es unknown
- 1994-02-18 IL IL108703A patent/IL108703A/en not_active IP Right Cessation
- 1994-02-18 AP APAP/P/1994/000622A patent/AP435A/en active
- 1994-02-18 LT LTIP1874A patent/LT3214B/lt not_active IP Right Cessation
- 1994-02-18 ZA ZA941137A patent/ZA941137B/xx unknown
-
1995
- 1995-08-18 FI FI953899A patent/FI953899A/fi unknown
- 1995-08-18 NO NO953254A patent/NO953254L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX9401294A (es) | 1994-08-31 |
| CN1118138A (zh) | 1996-03-06 |
| CA2155830A1 (en) | 1994-09-01 |
| IL108703A (en) | 1998-01-04 |
| TW279864B (pl) | 1996-07-01 |
| ZA941137B (en) | 1995-10-25 |
| JPH08506821A (ja) | 1996-07-23 |
| PL174836B1 (pl) | 1998-09-30 |
| LT3214B (en) | 1995-04-25 |
| NZ261854A (en) | 1997-04-24 |
| NO953254D0 (no) | 1995-08-18 |
| RU2128659C1 (ru) | 1999-04-10 |
| LTIP1874A (en) | 1994-09-25 |
| US5650411A (en) | 1997-07-22 |
| AU6108194A (en) | 1994-09-14 |
| NO953254L (no) | 1995-09-11 |
| AP9400622A0 (en) | 1994-04-30 |
| FI953899A (fi) | 1995-08-18 |
| HU9501923D0 (en) | 1995-09-28 |
| AU675508B2 (en) | 1997-02-06 |
| EP0684821A1 (en) | 1995-12-06 |
| IL108703A0 (en) | 1994-05-30 |
| AP435A (en) | 1995-11-17 |
| HUT73662A (en) | 1996-09-30 |
| PL310348A1 (en) | 1995-12-11 |
| WO1994018978A1 (en) | 1994-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI953899A0 (fi) | Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi | |
| NO934304L (no) | Fremgangsmaate for behandling av fluoralumosilikatglass | |
| NO921777L (no) | Fremgangsmaate for fremstilling av isoparaffiner | |
| UA27911C2 (uk) | Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну | |
| FI945441A (fi) | Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi | |
| FI940769A (fi) | Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi | |
| IT9021645A0 (it) | Procedimento per il trattamento di torbide di raffineria | |
| TR25057A (tr) | Aritim camurlarinin degerlendirilmesine mahsus usul | |
| ITMI913465A0 (it) | Procedimento per la depurazione dell'1.1.1-trifluoro-2-fuoroetano | |
| KR930702990A (ko) | 섬유성 질병 치료제로서의 프로스타사이클린- 및 카르바사이클린 유도체 | |
| NO920049D0 (no) | Fremgangsmaate for fremstilling av 3-eksometylencefamsulfoksydestere | |
| NO913117L (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
| EE03027B1 (et) | Meetod 8-klorokinolooni derivaatide valmistamiseks | |
| FI953361A (fi) | Menetelmä substituoitujen indolonijohdannaisten valmistamiseksi | |
| NO920983L (no) | Fremgangsmaate for behandling av nevrodegenerative tilstander | |
| FI961178A0 (fi) | Menetelmä syklisten cis-1-amino-2-alkanolien valmistamiseksi | |
| FI923360A (fi) | Foerfarande foer framstaellning av dimetylacetoacetamid | |
| FI943660A0 (fi) | Menetelmä 3-karbonyyliandrostadieeni-17-karboksamidien valmistamiseksi | |
| FI971964A (fi) | Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi | |
| FI961553A0 (fi) | Menetelmä asemassa 2 mono- tai disubstituoitujen syklopentanonien valmistamiseksi | |
| KR890701106A (ko) | 과지혈증의 치료를 위한 옥소퀴나졸린 유도체의 용도 | |
| KR970020845U (ko) | 근골격계질환 치료보조용 테이프 | |
| NO924701D0 (no) | Amid-bundete pyridyl-benzosyrederivater for behandling avleukotrien-relaterte sykdommer | |
| LV5046A3 (lv) | 3-(2,2,2-trimetilhidrazinij)propionata dihidrata iegusanas panemiens | |
| FI930088A0 (fi) | Urinsamlare foer underlaettande av provtagning fraon barn |